Regional Transitional Cell Cancer of the Renal Pelvis and Ureter

8 clinical trials · Condition

Record	Firm	Date
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers (NCT01846520)	City of Hope Medical Center	2013-10-01
Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer (NCT01639521)	University of Southern California	2013-05-01
Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer (NCT01282333)	National Cancer Institute (NCI)	2011-01-01
Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function (NCT00478361)	M.D. Anderson Cancer Center	2007-04-01
Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium (NCT00363883)	National Cancer Institute (NCI)	2006-06-01
Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium (NCT00112905)	National Cancer Institute (NCI)	2005-10-01
Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract (NCT00112671)	National Cancer Institute (NCI)	2005-04-01
Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer (NCT00021099)	National Cancer Institute (NCI)	2001-06-01

Every clearance here is in the API, with alerts when new ones post.